Patents by Inventor Michael Robert Barbachyn

Michael Robert Barbachyn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6069141
    Abstract: The present invention provides novel substituted amionphenyl isoxazoline derivatives of formula I ##STR1## wherein R.sub.1 is H, alkyl, cycloalkyl, alkoxy, amino, or alkylamino; X and Y are the same and different and are H, F, or CH.sub.3 ; W is O, or S;Q is a 4-, 5-, 6-, 7-, or 9-membered heterocyclic moiety containing one or more nitrogen, sulfur and/or oxygen. The compounds of the invention are useful as antimicrobial agents for preventing and treating infectious diseases.
    Type: Grant
    Filed: February 3, 1999
    Date of Patent: May 30, 2000
    Assignee: Pharmacia & Upjohn Company
    Inventors: Michael Robert Barbachyn, Joel Morris, Donn G. Wishka, Gary J. Cleek, Richard Charles Thomas
  • Patent number: 5990136
    Abstract: The present invention provides compounds of formula 1 ##STR1## or pharmaceutical acceptable salts thereof wherein A and R.sub.1 are as defined in the claims which are antibacterial agents.
    Type: Grant
    Filed: August 15, 1997
    Date of Patent: November 23, 1999
    Assignee: Pharmacia & Upjohn Company
    Inventors: Michael Robert Barbachyn, Richard Charles Thomas, Gary J. Cleek
  • Patent number: 5736545
    Abstract: Compounds useful in the preparation of pharmaceutical preparations for the treatment of microbial infection where such compounds are of structural Formula I ##STR1## or pharmaceutically acceptable salts thereof wherein: R.sup.1 is --CHO, --COCH.sub.3, --COCHCl.sub.2, --COCHF.sub.2, --CO.sub.2 CH.sub.3, --SO.sub.2 CH.sub.3, or --COCH.sub.2 OH; X.sup.1 and X.sup.2 are independently H, F, or Cl; and Q is a five membered ting heterocycle (azolyl ring) of the general form: ##STR2## wherein A, B, and C are independently oxygen (O), nitrogen (N), sulfur (S) or Carbon (C). In all cases, the piperazine nitrogen atom is attached at the carbon atom of the carbon-nitrogen double bond.
    Type: Grant
    Filed: February 20, 1997
    Date of Patent: April 7, 1998
    Assignee: Pharmacia & Upjohn Company
    Inventors: Robert C. Gadwood, Michael Robert Barbachyn, Dana Scott Toops, Herman Walden Smith, Valerie Ann Vaillancourt
  • Patent number: 5708169
    Abstract: The present invention provides for new 5-amidomethyl, .alpha.,.beta.-saturated and--unsaturated butyrolactone antibacterial agents of formula I ##STR1## characterized by 3-aryl substituents that include, for example, indolinyl and phenyl substituted with zero (0) to two(2) halogen atoms and substituted in the para position with, e.g., piperazinyl, thiomorpholinyl (and corresponding sulfoxide and sulfone), thiazolidinyl (and sulfoxide and sulfone), morpholinyl, azetidinyl, pyrrolidinyl, piperidinyl, pyrrolyl, azepinyl, troponyl, 3,7-diazabicyclo?3.3.0!octan-3-yl, bridged thiazinyl or bridged oxazinyl moieties. In those cases where a ring nitrogen is present, then this is substituted to form an amide, formamide, sulfonamide, urethane, or alkylated with a wide variety of moieties.
    Type: Grant
    Filed: September 5, 1996
    Date of Patent: January 13, 1998
    Assignee: Pharmacia & Upjohn Company
    Inventors: Jackson B. Hester, Jr., Steven Joseph Brickner, Michael Robert Barbachyn, Douglas K. Hutchinson, Dana Scott Toops